Technology Development Board (TDB) supports inDNA Life Sciences Private Limited., Bhubaneshwar., Orissa
Pioneering DNA-Driven Healthcare Solutions
inDNA Life Sciences is the first DNA based Clinic and a molecular platform innovated to offer customized solutions for identification of DNA based changes and its impact on the health and disease outcome. In the last three decades, with the advent of high end technology and tools in Molecular Life sciences, there has been a transition from Blood/Serum/Sputum/Tissue, Protein based diagnostics to Nucleic Acid (DNA/RNA) based Diagnostics. With the completion of Human genome project and Next generation rapid DNA sequencing based platforms, there has been a global phenomenon of Molecular medicine.
inDNA Life Sciences has taken the first steps to personalize disease management by offering a range of DNA based solutions, to a range of clinical problems, in the fields of Cytogenetics, Cancer, Genetic Disorders and Mendelian defects.
inDNA is currently operating in the areas of Molecular Cytogenetics, Onco-Genetics, and Molecular Fertility &Pedia-Genetics. The company has successfully installed a one of its kind Next generation DNA sequencing platform which is a first among such Installation in Eastern India.The laboratory has also successfully tied up or collaborated with the leading clinicians in these fields. The tests currently offered by inDNA have been adequately validated in its own laboratory facility, while making an effort to create a database for the mutations pertinent to the population of Indian origin.
inDNA is a DSIR Govt of India certified Company with active Research and Development wing as well as Training division. inDNA is involved in training and certificate program in the areas of DNA based Molecular Techniques and assays such as Cell Culture, Cancer Histopathology, Bone marrow profiling NGS Sequencing etc. The certificate programs are well designed to cater to industry requirements as well as skill enhancements.
inDNA Life Sciences has set up centres in North India with Delhi as a Base and expanded far East with Kolkata as a Base to Guwahati. It has currently more than 12 centres in 6 different states and aims to have PAN India presence.
The inhouse R&D division is involved in the process of Continuous innovation to cater as per the requirement of Critical illnesses such as Cancer , Fertility, Paediatrics, and wellness. In the last 5 years the company has added more than 200+ tests to its portfolio and each test is indigenously validated and customised to Detect, Diagnose and Treat a particular ailment or condition at the molecular level. Therefore , the mantra of inDNA is to look for solutions for life inDNA.
Published on : 10th October, 2023